Alterity Therapeutics Limited (ASX:ATH)
Australia flag Australia · Delayed Price · Currency is AUD
0.5450
+0.0150 (2.83%)
Jul 31, 2026, 3:55 PM AEST

Alterity Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
6.645.444.023.925.124.34
Revenue Growth
22.02%35.32%2.63%-23.56%18.06%-
Gross Profit
6.475.313.83.634.763.98
Operating Income
-17.56-14.66-19.61-14.64-15.5-15.18
Net Income
-14.59-12.15-19.12-13.81-12.85-15.31
Earnings Per Share
-0.08-0.09-0.26-0.28-0.27-0.45
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
49.240.6612.6415.7734.8128.12
Total Debt
0.10.160.160.210.120.07
Net Cash (Debt)
49.140.512.4815.5634.6928.05
Net Cash Growth
21.23%224.55%-19.81%-55.13%23.67%206.12%
Net Cash Per Share
0.280.320.170.320.720.83

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-13.71-11.45-12.61-20.04-12.34-17.33
Capital Expenditures
---0.01-0.01-0.09-0.01
Free Cash Flow
-13.71-11.45-12.61-20.04-12.43-17.34
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
97.55%97.66%94.67%92.72%92.88%91.70%
Operating Margin
-264.66%-269.57%-487.82%-373.72%-302.56%-349.77%
Pretax Margin
-217.90%-222.10%-474.65%-349.87%-249.38%-352.78%
Profit Margin
-219.85%-223.35%-475.79%-352.54%-250.75%-352.78%
FCF Margin
-206.62%-210.54%-313.78%-511.78%-242.54%-399.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
17.8616.785.224.366.1113.45